Depressed people with memory problems ‘at increased Alzheimer’s risk’June 16th, 2009 - 12:42 pm ICT by ANI
Washington, June 16 (ANI): Depressed individuals with memory problems are more likely to develop Alzheimer’s disease compared to people who are not depressed, says a new study.
The research has been published in the June 16, 2009, print issue of Neurology, the medical journal of the American Academy of Neurology. However, the research also shows that the popular Alzheimer’s drug donepezil may delay the progression to Alzheimer’s disease for depressed people with mild cognitive impairment (MCI) or memory problems.
MCI is described as the period in-between normal aging and Alzheimer’s disease. A person with MCI experiences memory problems that are greater than expected with normal aging but does not show other symptoms of Alzheimer’s disease, such as difficulties in completing everyday activities.
To reach the conclusion, researchers followed 756 people with MCI who were between the ages of 55 and 91 for three years. Of those, 208 were diagnosed with depression using a test that measures the severity and intensity of a person’s depressive symptoms. For every one point increase on the test, a participant’s risk of developing Alzheimer’s disease went up by three percent.
“Our longer term findings add to the body of evidence that suggests depression is a major risk factor for Alzheimer’s disease,” said study author Po H. Lu, PsyD, assistant professor of neurology with the David Geffen School of Medicine at UCLA in Los Angeles.
“Since the drug donepezil has been shown to improve the behavioral symptoms of Alzheimer’s disease, our study also tested whether the drug would delay the progression to Alzheimer’s disease in people with memory problems,” the expert added.
Participants were given either vitamin E, donepezil or a placebo pill. The study found that at 1.7 years, among depressed people with mild cognitive impairment, 11 percent of those taking donepezil developed Alzheimer’s disease compared to 25 percent of those who took vitamin E or placebo. At 2.2 years, 14 percent of those taking donepezil developed Alzheimer’s compared to 29 percent of those who took vitamin E or placebo. Donepezil had little effect in the group of people who were not depressed.
“If we can delay the progression of this disease for even two years, it could significantly improve the quality of life for many people dealing with memory loss,” said Lu. (ANI)
- Blood test to detect Alzheimer's disease in offing - Aug 10, 2012
- Large doses of B-complex vitamins may help slow progression of dementia - Oct 26, 2010
- It's official: Men have more memory problems than women - Sep 07, 2010
- Apathy, depression may increase dementia risk - Jul 13, 2010
- Cheap vitamin pill halts memory loss in Alzheimer's - Sep 09, 2010
- Study Suggests Use Of Vitamin B Delays Alzheimer's Disease - Sep 12, 2010
- Improving brain plasticity could delay Alzheimer's onset in elderly - Mar 24, 2011
- Treating high BP, cholesterol, diabetes may delay Alzheimer's - Apr 14, 2011
- Computer-exercise combo prevents memory loss - May 02, 2012
- Vitamin B 'new weapon against Alzheimer's' - Sep 09, 2010
- Vitamin pill can help reverse memory loss - Sep 14, 2011
- MRI scans show structural brain changes in people at Alzheimer's risk - Nov 17, 2010
- Memory training can overcome forgetfulness - Mar 02, 2012
- Earliest signs that predict eventual onset of Alzheimer's - Jan 29, 2010
- Tobacco-derived compound prevents memory loss in Alzheimer's - Apr 28, 2011
Tags: american academy of neurology, assistant professor, body of evidence, david geffen school, david geffen school of medicine, david geffen school of medicine at ucla, depressed individuals, depressive symptoms, donepezil, everyday activities, medical journal, memory problems, mild cognitive impairment, mild cognitive impairment mci, people with mild cognitive impairment, placebo pill, risk factor, school of medicine, study author, vitamin e